SCHEMBL10185550

SCHEMBL10185550

Bc1cccc(N(C(=O)Cn2ccnc2C)C2C(=O)N(C3CCCCC3)c3ccccc32)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 7/20 0.44
▸ OPRM1 P35372 3/20 0.36
▸ OPRK1 P41145 3/20 0.36
▸ OPRL1 P41146 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.32
▸ ALPL P05186 2/20 0.31
▸ ALPG P10696 2/20 0.31
▸ TSHR P16473 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ ALPI P09923 1/20 0.31
▸ PLAA Q9Y263 1/20 0.31
▸ CCKBR P32239 2/20 0.31
▸ CCKAR P32238 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ GFER P55789 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10185959 0.91 IDH1 (0.52) IDH1OPRM1OPRK1OPRL1CCKBR
SCHEMBL10185987 0.91 IDH1 (0.42) IDH1OPRM1OPRK1OPRL1KDM4E
SCHEMBL10183799 0.91 IDH1 (0.42) IDH1OPRM1OPRK1OPRL1KDM4E
SCHEMBL10185834 0.88 IDH1 (0.39) IDH1OPRM1OPRK1OPRL1KDM4E
SCHEMBL10185988 0.87 IDH1 (0.39) IDH1OPRM1OPRK1OPRL1TSHR
SCHEMBL10183771 0.86 IDH1 (0.39) IDH1OPRM1OPRK1OPRL1CCKBR
SCHEMBL10183793 0.85 IDH1 (0.39) IDH1OPRM1CCKBRCCKAR
SCHEMBL10184173 0.84 OPRM1 (0.37) IDH1OPRM1OPRK1OPRL1KDM4E
SCHEMBL10185886 0.83 IDH1 (0.46) IDH1OPRM1OPRK1OPRL1CCKBR
SCHEMBL10185724 0.82 IDH1 (0.42) IDH1OPRM1OPRK1OPRL1CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback